Allergodil nasal spray with a dispenser-spray 140 mcg / dose, 10 ml
Category
Allergy
Scope of the drug
Ear, Throat, Nose
Release form
Spray
Manufacturer country
Germany
Package quantity, pcs
one
Allergodil spr.
called
dosage.
140 mcg / dose vial
10ml No. 1 (with a spray dispenser)
Name ENG
ALLERGODIL
Clinical and pharmacological group
Antiallergic drug for topical use in ENT practice
ATX code
Azelastine
Dosage
140mcg / dose x 10ml
Structure
1 dose contains:
.Active substance: azelastine hydrochloride 0.140 mg. Excipients: hypromellose 0.140 mg
disodium edetate dihydrate 0.700 mg
citric acid 0.061 mg
sodium hydrogen phosphate dodecahydrate 0.907 mg
sodium chloride 0.961 mg, purified water 138.419 mg.
Indications
Treatment of seasonal and perennial allergic rhinitis (including hay fever) and rhinoconjunctivitis.
Treating symptoms of vasomotor (perennial non-allergic) rhinitis, such as nasal congestion, rhinorrhea, sneezing, postnasal syndrome.
Contraindications
Hypersensitivity to azelastine and / or other components of the drug
For allergic rhinitis and rhinoconjunctivitis - children under 6 years of age
with vasomotor rhinitis - children under 12 years of age.
Storage conditions and periods
At a temperature of 8-25 degrees.
Expiration date: 3 years
after opening - 6 months
INN / Active ingredient
Azelastine
Specifications
Category
Allergy
Scope of the drug
Ear, Throat, Nose
Release form
Spray
Manufacturer country
Germany
Package quantity, pcs
one
Scope of application
Allergology
Minimum age from
6 years
Way of introduction
Intranasally
Vacation conditions
Without recipe
Shelf life after opening
6 months
Volume, ml.
10 ml
Brand name
Medana
The amount of the dosage form in the primary package
10 ml
Primary packaging type
Bottle
Type of consumer packaging
Pack of cardboard
Anatomical and therapeutic characteristics
R01AC03 Azelastine
Dosage form
Dosed nasal spray
The target audience
Children
Expiration date in days
1095
Dosage (volume) of the substance in the preparation
azelastine hydrochloride 140 mcg
Package weight, g
ten
Mode of application
:
Intranasally.
< br> Allergic rhinitis and rhinoconjunctivitis:
< br> In the absence of other recommendations for adults and children 6 years and older - one dose (140 μg / 0.14 ml) in each nasal passage twice a day, morning and evening.
If necessary, adults and children over 12 years of age - two doses (280 mcg / 0.28 ml) in each nasal passage twice a day, morning and evening.
Allergodil is used until symptoms stop and is suitable for continuous use, but not more than 6 months of continuous treatment.
< br> Vasomotor rhinitis:
< br> Adults and children over 12 years old - two doses (280 mcg / 0.28 ml) in each nasal passage twice a day, morning and evening.
Allergodil is used until symptoms stop and is suitable for long-term use, but not more than 8 weeks of continuous treatment.
The volume of one injection (one dose) is 0.14 ml and contains 140 μg of active substance.
Pharmaco-therapeutic group
:
Antiallergic agent - H1-histamine receptor blocker